Skip to content
Open access

Cancer Distribution Pattern in the City of Kenitra, Morocco (2017-2022): A Pathology-Based Study.

Jul 2026 · Asian Pacific Journal of Cancer Prevention · Vol 27 7, pp. 2663-2671 · 0 citations · 35 references
Medicine

TL;DR

The high rates of bladder and skin cancer in this area warrant further epidemiological studies to identify etiological factors, develop control programs, and formulate prevention strategies.

Abstract

Background

Cancer epidemiological surveillance is essential for implementing an effective prevention policy. In Morocco, only two population-based cancer registries (Rabat and Casablanca), along with a limited number of local studies, provide data on cancer incidence. This report aims to describe the pattern of cancer incidence rates in the region of Kenitra.

Methods

This was a pathology-laboratory-based retrospective and descriptive study of all newly diagnosed cancers in public and private pathology laboratories in Kenitra between January 2017 and December 2022. Data on gender, age, and cancer locations were collected from medical records. Statistical analysis was limited to descriptive statistics, including frequencies, percentages, crude incidence rates, and age-standardized rates.

Results

2,682 cancer cases were recorded, with 1,535 males (57.23%) and 1,147 females (42.77%). The female-to-male ratio is 0.74. The median age at diagnosis was 59 (55 for females and 62 for males). The crude incidence rate was 254 per 100,000 population (291 per 100,000 for males and 217 per 100,000 for females). The overall age-standardized rate (ASR) was 283 per 100,000 (162 per 100,000 for males and 120 per 100,000 for females). The leading cancers among males were prostate (34.31%), bladder (19.27%), skin (13.54%), non-Hodgkin lymphoma (5.34%), stomach (3.97%), lung (3.84%), and colon (3.84%). The leading cancers among females were breast (27%), skin (15%), cervix (8%), non-Hodgkin lymphoma (5%), thyroid (5.49%), uterus (5%), and stomach (3.83%).

Conclusion

Our study is the first to explore the occurrence of cancers in the city of Kenitra. The high rates of bladder and skin cancer in this area warrant further epidemiological studies to identify etiological factors, develop control programs, and formulate prevention strategies.

Read PDF

Similar papers

Review Open access Jul 2026

The state of cancer in Somalia: a comprehensive six-year retrospective study.

Light is shed on the prevalence of cancer in Somalia and the dire need for accessible and affordable oncology services in Somalia and the urgent to need to establish national or population-based cancer registries to determine cancer incidence, identify risk factors, and create national plan for cancer prevention, control, and treatment.

Abdiasis M Hussein · 0 citations
Open access Aug 2026

Prevalence of Cancer in the Middle Region of Libya According to the National Cancer Institute of Misurata In 2022

The results of the statistical analysis revealed that the 51–60 age group exhibited the highest cancer frequency, accounting for 22.9%, whereas the 11–20 age group registered the lowest proportion, at just 1.9%.

Walid Naamat, Mohammed Abosalah, Ahmed Albakoush et al. · 0 citations
Open access Aug 2026

Trends in cervical cancer incidence and mortality in Mongolia, 2014–2024: a population-based analysis of pandemic-related disruptions

Divergent trends between incidence and mortality likely reflect reduced detection during the pandemic rather than true changes in disease burden, and highlight the importance of maintaining continuity of cancer screening and diagnostic services during health-system disruptions.

Nomin-Erdene Tsogtgerel, Dolgorkhand Adiyadorj, Gan-Erdene Ganbaatar et al. · 0 citations
Open access Jul 2026

Epidemiological Characteristics and Trends of Childhood Cancer in Eastern Libya: A Five-Year Retrospective Study

Cancer is a major global public health challenge and remains one of the leading causes of morbidity and mortality worldwide. It is the second leading cause of death after cardiovascular diseases globally and ranks among the leading causes of death in developing countries. This study aimed to describe the trends and epidemiological characteristics of childhood malignancies in eastern Libya and evaluate cancer type frequency and demographic patterns at Benghazi Children's Hospital. A retrospective cross-sectional descriptive study was conducted using archived data from patients aged 0–16 years diagnosed with childhood cancers at Benghazi Children's Hospital between January 2018 and December 2022. Demographic data, clinical presentations, investigations, tumor types, disease stages, and patient outcomes were collected and analyzed. Among 75,015 hospital admissions, 362 (0.4%) were diagnosed with malignancy. Leukemia was the most common (37.5%), followed by brain tumors (17.4%) and lymphoma (10.4%). Male predominance was observed across all malignancies except brain tumors. The mean age was 6.05 ± 4.21 years, with 47.8% of patients under five years. Other tumors included Wilms' tumor (9.3%), neuroblastoma (6.6%), soft tissue sarcoma (4.9%), bone tumors (4.4%), retinoblastoma (4.1%), carcinoma (1.9%), and hepatoblastoma (0.5%). Common presentations included mass lesions (38.1%), pallor (34.3%), and appetite loss (26.9%). Advanced stages (III–IV) predominated, and 20.9% of patients died during treatment. Childhood cancer cases in eastern Libya increased by 38% over the five-year study period. Leukemia was the predominant malignancy, with most cases originating outside Benghazi. Late-stage presentation remains a significant challenge, highlighting the need for improved early detection and referral systems.

Hala Ammar · 0 citations
Open access Aug 2026

THE SILENT RISE OF PANCREATIC CANCER IN BRAZIL: MAGNITUDE AND REGIONAL CONTRASTS IN MORTALITY, 2010–2024

Changing magnitude and sociodemographic and territorial inequalities reveal changing magnitude and sociodemographic and territorial inequalities, supporting cause-specific prevention, timely diagnosis, comprehensive care, and improved mortality information.

Getúlio Antônio de Freitas Filho, Alana Coêlho Maciel, Karla Danielly Xaveiro da Silva et al. · 0 citations
Open access Aug 2026

Colorectal cancer incidence in Siberia and the Far East

OBJECTIVE: to analyze the incidence of colon cancer in the Siberian (SFD) and Far Eastern Federal Districts (FEFD) for 2019–2024. MATERIALS AND METHODS: a retrospective descriptive study of depersonalized data on the incidence of colorectal cancer (colon (C18), rectosigmoid junction (C19), rectum, anus and anal canal (C20-21) — ICD-10 codebook) was conducted for the period from January 2019 to December 2024 according to absolute data (the number of malignant neoplasms detected for the first time in life (table 2000) taking into account gender and age) of reporting forms No. 7 “Information on malignant neoplasms” of the subjects of the Siberian Federal District and the Far Eastern Federal District. Population data by gender and age for federal district subjects were provided by the Federal State Statistics Service of the Russian Federation. Standardized (world standard SEGI per 100,000 population (0/0000)) and age-specific incidence rates were calculated for 2019–2021 and 2022-2024. Differences in rates between periods were assessed using 95% confidence intervals (CI). RESULTS: in the structure of morbidity, colorectal cancer (CRC) consistently ranks 3rd among both men (12.0 and 11.1% in the Siberian Federal District and the Far Eastern Federal District) and women (11.5 and 10.8%). In the Siberian Federal District, standardized incidence rates when comparing 2019–2021 and 2022–2024 increased in the male population from 34.8 (95% CI 34.2–35.4) to 40.4 (95% CI 39.7–41.1) 0/0000 and in the female population from 24.4 (95% CI 24.0–24.9) to 26.7 (95% CI 26,2–27.1) 0/0000. In the Far Eastern Federal District — from 29.5 (95% CI 28.7–30.4) to 33.0 (95% CI 32.1–33.9) 0/0000 and from 22.3 (95% CI 21.7–22.9) to 24.4 (95% CI 23.8–25.1) 0/0000. In the Siberian Federal District, an increase in the incidence of CRC in men and women is observed after 45 years of age. The peak incidence occurs at 75–79 years, reaching 420.2 0/0000 in men and 252.0 0/0000 in women. In the FEFD, among men, the incidence increase is observed after age 50, with a peak at 75–79 years (377.3 0/0000); among women, after age 55, with the highest age-specific rate at 75–79 years (249.3 0/0000). CONCLUSION: analysis of colorectal cancer incidence in the Siberian and Far Eastern Federal Districts revealed an increase in rates among both sexes, with the highest values in age groups over 70 years, which indicates the relevance of introducing territorially adapted colon cancer screening programs, with a focus on high-risk groups taking into account age.

L. D. Zhuikova, O. Ananina, G. Kononova et al. · 0 citations